🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neuroendocrine Tumors

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma NCT04594187Phase 23 sites📍 Jacksonville📍 Camden📍 Houston M.D. Anderson Cancer Center · Tests: Immunotherapy, Quality-of-Life Assessment, Radiation Therapy Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009n/a1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Pancreatic elastase-1 in blood serum A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site📍 Shanghai Hansoh BioMedical R&D Company · Tests: HS-20108 Monotherapy An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site📍 Padova Azienda Ospedaliera di Padova Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma NCT07704918NA1 site📍 Aurora University of Colorado, Denver · Tests: Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evol… DermaSensor Postmarket Surveillance Study NCT06666790NA2 sites📍 New Smyrna Beach📍 Morehead City DermaSensor, Inc. · Tests: Scan with elastic scattering spectroscopy device to assess risk of malignancy A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma NCT06581406Phase 2, Phase 333 sites📍 Scottsdale📍 La Jolla📍 Los Angeles Replimune, Inc. · Tests: RP2, Ipilimumab, Nivolumab A Study of IBI363 in Subjects With Advanced Melanoma NCT06081920Phase 212 sites📍 Beijing📍 Beijing📍 Fuzhou Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI363 Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. NCT07463625n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Data-only evaluation of [18F]FET PET, pituitary MRI, and biomarkers Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia NCT07422779NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Pembrolizumab, Nivolumab, Ipilimumab A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients NCT01638676Phase 1, Phase 21 site📍 Louisville University of Louisville · Tests: Vemurafenib, Metformin Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies NCT06508775NA7 sites📍 Berlin📍 Cologne📍 Erlangen Miltenyi Biomedicine GmbH · Tests: MB-CART19.1, MB-CART20.1, MB-CART2019.1 TIL Therapy in cSCC and MCC NCT07288073Phase 21 site📍 Boston Karam Khaddour, MD, MS · Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC NCT07416695Phase 12 sites📍 Beijing📍 Shanghai Shanghai Henlius Biotech · Tests: HLX3901 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site📍 Beijing Peking University Third Hospital · Tests: 68Ga-SorB PET/CT The NF Registry Sponsored by the Children's Tumor Foundation NCT01885767n/a1 site📍 New York The Children's Tumor Foundation Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients NCT04917484Phase 21 site📍 Aarhus Tine Gregersen, MD · Tests: Lu-177-DOTA-Octreotide Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide Lenvatinib Plus Chemotherapy for pNET Liver Metastases NCT07835893Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Lenvatinib, Chemotherapy COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study NCT07354152n/a1 site📍 Nantes Nantes University Hospital The MELAcare Study: A New Method for Surveillance of Melanoma Patients NCT05253872NA1 site📍 Copenhagen Herlev and Gentofte Hospital · Tests: The MelaCare intervention Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision NCT06279299NA1 site📍 Beijing National Cancer Center, China · Tests: lateral pelvic lymph node dissection Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma NCT05830058Phase 22 sites📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Biospecimen Collection, Computed Tomography, Positron Emission Tomography, Questionnaire Administration, Stereotactic B… Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC NCT07138716NA1 site📍 Beijing Luo Yaping · Tests: 68Ga-DOTA-CCK-FS PET/CT DLL3-Targeted PET/CT in Neuroendocrine Carcinoma NCT07458906NA1 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Diagnostic Test: conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT A Study of Armored CAR T Cells in People With Cancer NCT07783477Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: DLL3-SAVVYZ-IL18 CAR T cell Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade NCT07661966NA1 site📍 New York Weill Medical College of Cornell University · Tests: Bright Light Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy